Pricing
  1. US-listed companies
  2. Bionik Laboratories Corp.
  3. Financials
  4. Net income

Bionik Laboratories Corp. (BNKL)

Market cap
$12.48
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Mar 31, 2023-5-52.48%
Mar 31, 2022-10-23.59%
Mar 31, 2021-14-154.45%
Mar 31, 202025+136.97%
Mar 31, 201911-172.18%
Mar 31, 2018-15+271.54%
Mar 31, 2017-4-29.63%
Dec 31, 2015-6+119915.15%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat